Therapietrouw bij psychotische stoornissen: orale versus langwerkende injecteerbare antipsychotica
Tijdschrift voor Geneeskunde en Gezondheidszorg · 31.03.2026
DOI: 10.47671/tvg.82.25.080 ↗Kurz gefasst
Fachartikel in der Zeitschrift Tijdschrift voor Geneeskunde en Gezondheidszorg, online erschienen am 31.03.2026. Verfasst von G. HEYLENS und 1 weiteren Autor:innen. Die Arbeit nennt 41 Literaturangaben.
Abstract (Originalsprache)
Medication adherence in psychotic disorders: oral versus long-acting injectable antipsychotics Background: Adherence is crucial in the treatment of psychotic disorders. Non-adherent patients face an increased risk of relapse, rehospitalization, and impaired functioning. Long-acting injectable antipsychotics (LAIs) are often used to improve adherence, but the literature shows no consensus when compared to oral antipsychotics (OAs).
Objective
To examine whether a difference in adherence exists between OAs and LAIs in adults with a psychotic disorder.
Methods
A literature review was conducted of studies published in the past 10 years comparing adherence between OAs and LAIs. 30 studies were included, of which 2 were randomized controlled trials (RCTs). The most frequently used adherence measures were proportion of days covered (PDC) and medication possession ratio (MPR).
Results
19 studies, including 1 RCT, reported significantly better adherence with LAIs. 3 studies found no difference, while 1 study reported higher PDC scores for OAs. 7 studies showed mixed results, often depending on the type of antipsychotic: second-generation LAIs, such as paliperidone palmitate, generally outperformed OAs, whereas first-generation LAIs sometimes performed worse. The limited number of RCTs, the retrospective design of most studies, and the absence of standardized adherence measures hinder interpretation. Furthermore, the commonly used PDC threshold of 80% is not evidence-based.
Conclusion
Although LAIs are associated with higher adherence than OAs in several studies, the evidence remains mixed and methodologically limited. The choice of formulation should be individualized and discussed with the patient. Large-scale, standardized research is needed to better assess adherence and refine treatment recommendations.
Zitieren
APA
HEYLENS, G., & AELBRECHT, A. (2026). Therapietrouw bij psychotische stoornissen: orale versus langwerkende injecteerbare antipsychotica. Tijdschrift voor Geneeskunde en Gezondheidszorg. https://doi.org/10.47671/tvg.82.25.080
Vancouver
HEYLENS G, AELBRECHT A. Therapietrouw bij psychotische stoornissen: orale versus langwerkende injecteerbare antipsychotica. Tijdschrift voor Geneeskunde en Gezondheidszorg. 2026. doi:10.47671/tvg.82.25.080
BibTeX
@article{HEYLENS2026,
author = {HEYLENS, G. and AELBRECHT, A.},
title = {Therapietrouw bij psychotische stoornissen: orale versus langwerkende injecteerbare antipsychotica},
journal = {Tijdschrift voor Geneeskunde en Gezondheidszorg},
year = {2026},
doi = {10.47671/tvg.82.25.080}
}
EUVIMED